Analyze Diet
American journal of veterinary research2022; 83(10); ajvr.22.04.0072; doi: 10.2460/ajvr.22.04.0072

Therapeutics prior to mesenchymal stromal cell therapy improves outcome in equine orthopedic injuries.

Abstract: Mesenchymal stromal (stem) cells (MSCs) have been studied to treat many common orthopedic injuries in horses. However, there is limited information available on when and how to use this treatment effectively. The aim of this retrospective study is to report case features, treatment protocols, and clinical outcomes in horses treated with MSCs. Methods: 65 horses presenting with tendinous, ligamentous, and articular injuries, and treated with MSCs prepared by a single laboratory between 2016 and 2019. Outcome information was available for 26 horses. Methods: Signalment, clinical signs, diagnostic methods, treatment protocol features (prior and concurrent therapies, cell origin, dose, application site and number), and effective outcomes were analyzed. The analysis was focused on comparing the effect of different MSC treatment protocols (eg, autologous vs allogeneic) on outcome rather than the effectiveness of MSC treatment. Results: MSC treatment resulted in 59.1% (clinical lameness) to 76.9% (imaging structure) improvement in horses with diverse ages, breeds, sex, and lesions. The use of other therapeutic methods before MSC application (eg, anti-inflammatories, shockwave, laser, icing, resting, bandage and stack wrap, intra-articular injections, and/or surgical debridement) was shown to be statistically more effective compared to MSCs used as the primary therapeutic procedure (P < .05). Autologous versus allogeneic treatment outcomes were not significantly different. Conclusions: A prospective MSC treatment study with standardization and controls to evaluate the different features of MSC treatment protocols is needed. The various case presentations and treatment protocols evaluated can be used to inform practitioners who are currently using MSCs in clinical practice.
Publication Date: 2022-08-18 PubMed ID: 35973004DOI: 10.2460/ajvr.22.04.0072Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article explores the usage and effectiveness of mesenchymal stromal (stem) cell therapy in treating orthopedic injuries in horses, and highlights that utilizing other therapeutic methods before this therapy can significantly improve outcomes.

Objective and Methods of the study

For the study, the researchers retrospectively looked at horse cases presenting with several types of orthopedic injuries (tendinous, ligamentous, and articular injuries) that had been treated with mesenchymal stromal cells (MSCs). They included 65 horses that had been treated between 2016 and 2019 and for which they had outcome information for 26 horses. The objective was not to assess the effectiveness of MSC treatment itself, but rather how various treatment protocols affected the outcome.

  • Factors like the horse’s signalment, clinical signs, diagnostic methods used were taken into consideration along with the treatment protocol features—therapies prior to and concurrent with MSC therapy, the origin of the cell, dose used, the site of application, and the number of treatments given.
  • The study looked to compare the impact of different MSC treatment protocols—for instance, autologous vs allogeneic—on the treatment outcome.

Outcome

The use of MSC treatment resulted in an improvement ranging from 59.1% (in clinical lameness) to 76.9% (in imaging structure) in horses of different ages, breeds, sex, and with different types of lesions.

Primary Findings

Several important findings were revealed through this study.

  • It was discovered that using other therapeutic methods before MSC application—like anti-inflammatories, shockwave, laser, icing, resting, bandaging and stack wrapping, intra-articular injections, and/or surgical debridement—had more effective results compared to using MSCs as the first method of therapy.
  • In addition, no significant difference was found between autologous and allogeneic treatment outcomes, and both treatment types were deemed effective.

Conclusions and Recommendations

The study concluded by suggesting a need for a prospective study on MSC treatment with standardization and controls to evaluate the different aspects of the treatment protocols. The diverse case presentations and treatment protocols analyzed can be used to inform practitioners who are currently employing MSC therapy in their practice.

Cite This Article

APA
Bernardino PN, Smith WA, Galuppo LD, Mur PE, Cassano JM. (2022). Therapeutics prior to mesenchymal stromal cell therapy improves outcome in equine orthopedic injuries. Am J Vet Res, 83(10), ajvr.22.04.0072. https://doi.org/10.2460/ajvr.22.04.0072

Publication

ISSN: 1943-5681
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 83
Issue: 10
PII: ajvr.22.04.0072

Researcher Affiliations

Bernardino, Pedro N
  • Department of Veterinary Medicine and Epidemiology, Veterinary Institute for Regenerative Cures, School of Veterinary Medicine, University of California, Davis, CA.
Smith, Woutrina A
  • Department of Veterinary Medicine and Epidemiology, One Health Institute, School of Veterinary Medicine, University of California, Davis, CA.
Galuppo, Larry D
  • Department of Surgical and Radiological Sciences, Veterinary Institute for Regenerative Cures, School of Veterinary Medicine, University of California, Davis, CA.
Mur, Pablo Espinosa
  • Department of Pathology, Microbiology and Immunology, Veterinary Institute for Regenerative Cures, School of Veterinary Medicine, University of California, Davis, CA.
Cassano, Jennifer M
  • Department of Veterinary Medicine and Epidemiology, Veterinary Institute for Regenerative Cures, School of Veterinary Medicine, University of California, Davis, CA.

MeSH Terms

  • Animals
  • Horses / injuries
  • Injections, Intra-Articular / veterinary
  • Joints / injuries
  • Ligaments / injuries
  • Mesenchymal Stem Cell Transplantation / veterinary
  • Mesenchymal Stem Cells / physiology
  • Retrospective Studies
  • Tendon Injuries / therapy
  • Tendon Injuries / veterinary

Citations

This article has been cited 1 times.
  1. Cassano JM, Leonard BC, Martins BC, Vapniarsky N, Morgan JT, Dow SW, Wotman KL, Pezzanite LM. Preliminary evaluation of safety and migration of immune activated mesenchymal stromal cells administered by subconjunctival injection for equine recurrent uveitis. Front Vet Sci 2023;10:1293199.
    doi: 10.3389/fvets.2023.1293199pubmed: 38162475google scholar: lookup